Question for those more informed on trials etc.
Post# of 148280
Why not just have an end point re the ability to treat cytokine storm. ie. the reduction of the IL's.
Could we apply for an approval then just on that ? That would decouple the results from the state of the patient (and other associated medical complications). That in DrBP's paper to me was the big take away. Even those that passed away, still showed the 3 day reduction.